Justera Receives P.O. to Supply to Costco

Toronto, Ontario–(Newsfile Corp. – November 2, 2023) – Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (“Justera” or the “Company“) is pleased to announce that the Company’s wholly-owned subsidiary, Naturevan Nutrition Ltd., (“Naturevan“), received a Purchase Order (P.O.) to supply to Costco Korea for $100,000 on November 1, 2023.

On October 30, 2023, the Company announced the agreement to supply to Costco Korea through its distributor, JS Foods Global (“JS Foods“), a health food distributor with operations spanning the U.S.A., South Korea, Japan, and Canada. This agreement will facilitate the distribution of Naturevan’s premium health products to Costco Wholesale Korea Ltd., (“Costco Korea“).

This P.O. is a significant development in the Company’s ongoing commitment to providing its top-quality health food products to consumers around the world.

We are excited to announce the purchase order to Costco Korea through valued distributor, JS Foods. This achievement marks a crucial milestone in our long-term partnership, reflecting our commitment to delivering premium health products globally. This success fuels our dedication to excellence and development,” said Edward Park, Chief Executive Officer of the Company.

About Costco

Costco is a prominent retail chain that brings the wholesale warehouse shopping experience. Known for its wide selection of quality products, competitive prices, and membership-based model, Costco caters to both individual shoppers and businesses. With a commitment to value, convenience, and a diverse range of goods, Costco has established itself as a go-to destination for those seeking cost-effective and high-quality shopping solutions.

To learn more, please visit: https://www.costco.com.

About JS Foods

JS Foods introduces healthy food from around the world to consumers to enjoy at home and abroad using a global network. JS Foods is based on years of research and development to ensure a high standard of quality healthy food. The company creates natural healthy foods without additives or chemicals. The global brand is made up of different health food brands spanning across the globe to provide their exclusive health food brand.

To learn more about JS Foods Global, please visit: www.jsglobal.com.

About Justera

Established in 2020, Justera Health Ltd. is a Canadian Company focused on health and wellness. Through its services, innovative products, strategic partnerships, Justera empowers individuals to prioritize their well-being. With four subsidiaries, it offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Justera’s mission is to enhance Canadians overall well-being with diverse solutions catering to individual needs.

For additional information on Justera and other corporate information, please visit the Company’s website at www.justerahealth.com.

For more information about the Company, please refer to the Company’s profile on SEDAR+ at www.sedarplus.com.

Neither the Canadian Securities Exchange (the “CSE”) nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information:

Investor Relations & Communications

Edward Park, Chief Executive Officer
Tel: (416) 901-5611 x 203
Email: epark@justerahealth.com

Forward-Looking Statements:

Certain statements contained in this news release may constitute forward-looking information, including statements relating to the future development of Justera’s business. Forward-looking information is often, but not always, identified by the use of words such as “anticipate”, “plan”, “estimate”, “expect”, “may”, “will”, “intend”, “should”, and similar expressions. Forward-looking information involves known and unknown risks, uncertainties, and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking information. The actual results of Justera could differ materially from those anticipated in this forward-looking information as a result of regulatory decisions, competitive factors in the industries in which Justera operates, prevailing economic conditions, changes to Justera’s strategic growth plans, and other factors, many of which are beyond the control of Justera. Management of Justera believes that the expectations reflected in the forward-looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents Justera’s expectations as of the date hereof and is subject to change after such date. Justera disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events, or otherwise, except as required by applicable securities legislation.

###

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/186112

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

3 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

4 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

4 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

5 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago